awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39732691-16AE1DC6-5742-4233-87EB-62B78E0E5EED
Q39732691-16AE1DC6-5742-4233-87EB-62B78E0E5EED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39732691-16AE1DC6-5742-4233-87EB-62B78E0E5EED
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
P2860
Q39732691-16AE1DC6-5742-4233-87EB-62B78E0E5EED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39732691-16AE1DC6-5742-4233-87EB-62B78E0E5EED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f5bdb22deb272643d680979981b85b49ce6c954
P2860
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.